Vanderbilt University Medical Center
Radiation Oncology residency · Nashville, TN · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is Vanderbilt University Medical Center's research in radiation oncology, which the program shares with other departments and affiliated hospitals.
About Vanderbilt University Medical Centerinstitution-wide radiation oncology research
Radiation Oncology publications from Vanderbilt University Medical Center and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
344
works per year
11th of 47 radiation oncology residency programs
+6.6%
2-year growth
31st of 47 radiation oncology residency programs
25.8%
in top 10% of field (works before 2025)
10th of 47 radiation oncology residency programs
46.9%
cited above world average
11th of 47 radiation oncology residency programs
Works per year · * 2026 so far
Oncology · 1,121Radiology, Nuclear Medicine and Imaging · 547
Radiation Oncology research topics at Vanderbilt University Medical Center
Papers in the window; each links to the list on OpenAlex.
- Cancer Immunotherapy and Biomarkers 241
- CAR-T cell therapy research 157
- Advanced Neuroimaging Techniques and Applications 122
- Advanced MRI Techniques and Applications 120
- Colorectal Cancer Treatments and Studies 76
- Pancreatic and Hepatic Oncology Research 55
- COVID-19 and healthcare impacts 53
- Cancer survivorship and care 49
Most cited at Vanderbilt University Medical Center since 2024
All radiation oncology papers there on OpenAlex
- The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Lisa M Force et al. · The Lancet · 2025 · PubMed · cited 498
- Colorectal cancerCathy Eng et al. · The Lancet · 2024 · PubMed · cited 480
- Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in OncologyAl B. Benson et al. · Journal of the National Comprehensive Cancer Network · 2024 · PubMed · cited 406
- Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trialSandra P. D’Angelo et al. · The Lancet · 2024 · PubMed · cited 319
- NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024Al B. Benson et al. · Journal of the National Comprehensive Cancer Network · 2024 · PubMed · cited 312
- Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In OncologyJaffer A. Ajani et al. · Journal of the National Comprehensive Cancer Network · 2025 · PubMed · cited 243
- Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 8-year follow-up results of efficacy and safety from the phase III CheckMate 214 trialNizar M. Tannir et al. · Annals of Oncology · 2024 · PubMed · cited 236
- Management of Locally Advanced Rectal Cancer: ASCO GuidelineAaron James Scott et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 204
- Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Kayleigh Pavitra Bhangdia et al. · The Lancet Oncology · 2026 · PubMed · cited 174
- Encorafenib, Cetuximab, and mFOLFOX6 in BRAF -Mutated Colorectal CancerElena Élez et al. · New England Journal of Medicine · 2025 · PubMed · cited 174